Skip to main content
. 2022 Nov 7;8(12):2396–2404. doi: 10.1021/acsinfecdis.2c00307

Figure 2.

Figure 2

Analysis of rifampicin potentiation by enantiomeric pairs PmxB4/ent-PmxB4 and PMBN/ent-PMBN against polymyxin-sensitive and polymyxin-resistant bacteria. (A) Checkerboard assays to assess the synergy of rifampicin with PmxB4/ent-PmxB4 and PMBN/ent-PMBN against polymyxin-sensitive E. coli ATCC 25922. (B) Checkerboard assays to assess the synergy of rifampicin with PmxB4/ent-PmxB4 and PMBN/ent-PMBN against polymyxin-resistant (mcr-1 positive) E. coli. Color corresponds to growth (as read by OD600) after incubation and with intensity proportional to the observed OD600 value. White areas indicate no growth. Bounded box indicates the combination of concentrations that gives the lowest FIC index value. Values used for FICI calculations are shown in Table S4.